Merriman Curhan Ford
View Older Stories View More Recent Stories
-
Merriman, Curhan Ford Downgrades Akamai Technologies (AKAM) to Sell
-
Merriman Curhan Ford Reiterates a 'Buy' on VIVUS (VVUS)
-
Notable Analyst Rating Changes 9/28: CSCO, VPHM, ACN, AMAT, GD Upgraded; RBS, WFR, ISRG, WXS Downgraded
-
Merriman Curhan Ford Initiates Coverage on Facet Biotech (FACT) with a Buy
-
Merriman Curhan Ford Initiates Coverage on Acorda Therapeutics (ACOR) with a Neutral
-
Notable Analyst Rating Changes 9/18: ETFC, SNDK, TOL, SBUX, PG, AMED Upgraded; SCHW, GENZ, MDC, IMAX, MOT Downgraded
-
Merriman Curhan Downgrades IMAX (IMAX) to Neutral
-
Merriman Curhan Ford Downgrades IMAX Corporation (IMAX) to Neutral; Valuation Call
-
Merriman Curhan Ford Initiates Coverage on Electronic Game Card (EGMI) with a Buy
-
Analyst Says ADBE/OMTR Deal Highlights Cheap Valuation of LivePerson (LPSN)
-
Merriman Curhan Ford (MERR) CEO Buys 27K Shares; CFO Buys 5K
-
Merriman Curhan Ford Initiates Coverage on Intevac (IVAC) with a Buy
-
Merriman Curhan Ford Initiates Coverage on Abraxis BioScience (ABII) with a Buy
-
Merriman Curhan Ford Initiates Coverage on Intevac (IVAC) with a Buy
-
Merriman Curhan Sees Another 20% Upside In Vivus (VVUS)
-
Merriman Curhan Initiates Coverage on International Rectifier (IRF) with a Buy
-
Merriman Curhan Ford Upgrades Walter Energy (WLT) to Buy
-
Morning Movers 8/28: MCZ, SVA, ARUN, OVTI, STM Higher; CPWM, ALTH, IMMU, NCTY Lower
-
Merriman Curhan Ford (MERR) Raises $10.2M, Settles $43.5M in Civil Legal Claims
-
Merriman Curhan Ford (MERR) Halted, News Pending
-
Notable Analyst Rating Changes 8/24: AXP, DELL, AMD, BBD, EAT Upgraded; NOK, TOL, SWHC, PNC, SYK Downgraded
-
Merriman Initiates Coverage on WPCS International (WPCS) with a Buy
-
Notable Analyst Rating Changes 8/21: SPWRA, GPS, CRM, LTD, UDR, JBL Upgraded; STP, DKS, INTU, LZ Downgraded
-
Merriman Curhan Ford Rates First Solar (FSLR) a Buy In Transitioned Coverage
-
Merriman Curhan Upgrades SunPower (SPWRA) To Buy In Transitioned Coverage
-
Merriman Curhan Ford Upgrades Super Micro Computer (SMCI) to Buy; Post 4Q Checks Suggest Improving Outlook.
-
Merriman Curhan Trims Price Target on Geron (GERN) Following FDA Clinical Hold
-
Merriman Curhan Initiates Coverage on InterMune (ITMN) with a Buy
-
Merriman Curhan Initiates Coverage on Salix Pharmaceutical (SLXP) with a Buy
-
Merriman Curhan Reiterates Bullish Stance On Dendreon (DNDN) Following Q2 Results/Call
-
Merriman Curhan Calls ValueClick (VCLK) A Great Value, Upgrades to Buy
-
Merriman Curhan Ford Upgrades Cree, Inc. (CREE) to Buy, LED Outlook Brighter
-
Merriman Curhan Reiterates Bullish Stance on Regeneron (REGN) Following "Vanilla" Q2
-
Merriman Curhan Ford Downgrades Ligand Pharmaceuticals (LGND) to Neutral
-
Notable Analyst Rating Changes 8/3: MMM, WEN, GPS, BIDU, JCP, OWW, NDAQ Upgraded; HURN, ANN, E, ROST Downgraded
-
Merriman Curhan Ford Starts Helix Biopharma Cp (HXBPF) at Buy
-
Unusual 11 Mid-Day Movers 7/31: ANDS, IBNK, INO, DSCM Higher; SYNA, ARIA, SFI, PIR Lower
-
Merriman Curhan Downgrades ARIAD Pharma (ARIA) to Sell
-
FUQI International (FUQI) Prices 4.86M Share Offering at $21.50
-
Merriman Curhan Ford Downgrades Akamai Technologies (AKAM) to Neutral; Stepping to Sidelines
-
Micromet (MITI) Announces Pricing of 14M Shares AT $5.00 Per Share
-
Merriman Curhan Maintains Bullish Stance On FUQI Intl (FUQI) Ahead of Equity Pricing
-
Notable Analyst Rating Changes 7/28: X, AA, ENOC, IR, UFS Upgraded; DB, PM, WGOV, CRM Downgraded
-
Merriman Curhan Initiates Coverage on VIVUS (VVUS) with a Buy
-
Merriman Curhan Initiates Coverage on Celgene (CELG) with a Buy
-
Merriman Curhan Initiates Coverage on Cinemark Holdings (CNK) with a Buy
-
Merriman Curhan Upgrades optionsXpress Holdings (OXPS) to Neutral
-
EMC (EMC) volatility low at 39 into EPS and margin outlook
-
Merriman Curhan Initiates Coverage on EMC Corp (EMC) with a Buy
-
Notable Analyst Rating Changes 7/15: GS, ALU, ICE, MCO, ADBE, MI Upgraded; PTR, PAR, UFS, PCL Downgraded
